BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.

To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.

To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.

Login Register Subscribe

California regulators seek comments on revised drug formulary rules

California regulators seek comments on revised drug formulary rules

Those wishing to opine on California’s upcoming drug formulary for injured workers have until 5 p.m. Aug. 2 to submit written comments, the Department of Industrial Relations’ Division of Workers’ Compensation announced on Tuesday. 

Regulators issued a modified version of the formulary Tuesday, after reviewing 119 pages of comments from the first 15-day period that ended on May 1. Tuesday’s announcement restarted the clock.

Meanwhile, the department announced in June that it would delay implementation of the formulary until Jan. 1, 2018 — one of the requests included in several comments submitted in the first round. 

The new, proposed changes include the same postponement date, along with other alterations, according to a press release. Among them: changing the “Preferred/Non-Preferred” drug designations to “Exempt/Non-Exempt” to better align with how the designations affect the prospective utilization review status of the drug; revised provisions relating to phased implementation of the formulary; deletion of provisions regarding issues that will be addressed in the utilization review regulations rather than in the formulary regulations; clarification of applicable dispute resolution procedures; and an updated drug listing and formatting changes. 



Read Next

  • California closed drug formulary proposal puts spotlight on opioids

    Doctors who wish to repeatedly prescribe opioids to injured workers in California starting July 1 will have to subject the claim to a review process, according to an overview of the proposed workers compensation prescription drug formulary set to go into effect next summer.